3

OWNERSHIP DOCUMENT

Company: Rani Therapeutics Holdings, Inc.
Filed: July 29, 2021
Period of Report: July 29, 2021
Accession Number: 0001104659-21-097820

View Document ↗ View on SEC.gov ↗